Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Chem Phys Lipids. 2013 Dec 21;178:84–91. doi: 10.1016/j.chemphyslip.2013.12.006

Table 1. Antibacterial activity of 2-AFAs and other analogues against Gram-positive and Gram-negative bacteria at 37°C after 18-24 ha.

Compound MIC/ IC50 ± SEM (μg/mL)

S. aureus (ATCC 29213) S. saprophyticus (ATCC 15305) B. cereus (ATCC 10876) E. coli (ATCC 25922) K. pneumoniae (ATCC 13883) P. aeruginosa (ATCC 27853)
2-HDA 15.6/6.2 ± 0.9 15.6/8.8 ± 0.1 31.3/17.2 ± 1.0 >1,000 7.8/6.1 ± 0.1 125/87.8 ± 1.1
2-ODA 15.6/8.1 ± 1.0 125/68.8 ± 3.5 15.6/11.9 ± 0.8 >1,000 7.8/5.6 ± 0.2 >1,000
2-ICA >1,000 >1,000 >1,000 >1,000 >1,000 >1,000
2,6-HDA 31.3/14.1 ± 0.1 62.5/21.5 ± 0.6 62.5/46.1 ± 0.3 >1,000 62.5/ 31.2 ± 0.5 250/132.3 ± 3.5
2,9-HDA 250/94.0 ± 0.9 125/61.5 ± 1.2 62.5/34.2 ± 0.3 >1,000 250/135.4 ± 0.7 >1,000
2-HDOTHP >1,000 >1,000 >1,000 >1,000 >1,000 >1,000
2-ODOTHP >1,000 >1,000 >1,000 >1,000 >1,000 >1,000
2-HDOH >1,000 >1,000 >1,000 >1,000 >1,000 >1,000
2-ODOH >1,000 >1,000 >1,000 >1,000 >1,000 >1,000
METH 0.06/0.03 ± 0.01 0.12/0.06 ± 0.01 62.5/38.2 ± 0.7 >1,000 0.98/0.36 ± 0.01 >1,000
CIPRO 0.25/0.14 ± 0.01 <0.002 0.05/0.03 ± 0.01 <0.008 0.24/0.13 ± 0.01 0.24/0.11 ± 0.01
a

Experiments were performed in triplicate (N =3). Meth, Methicillin, Cipro, Ciprofloxacin.